Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

By Kamat Siddhesh A.   Bullano Michael F.   Chang Chun-Lan   Gandhi Sanjay K.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 961-968

Informa Healthcare

Access to resources Recommend Favorite

Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement

By Chang Joanne   Yang Weiyi   Fellers Thomas   Kahler Kristijan H.   Orloff John   Xie Jipan   Tsaneva Magda   Yu Andrew P.   Wu Eric Q.  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2203-2212

Informa Healthcare

Access to resources Recommend Favorite

Comment and reply on: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination

By Vivencio Barrios   Norbert Braun  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2267-2269

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination

By Braun N.   Ulmer H.-J.   Ansari A.   Handrock R.   Klebs S.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 421-430

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

By Ley Ludwin   Schumacher Helmut  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite